Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4c066b3d8185874e461e8305530fe4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-604 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-603 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_018438197d44ef208a5f390d13adb96d |
publicationDate |
2014-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014167943-A1 |
titleOfInvention |
Protein-containing component for inducing cell re-programming, method for manufacturing pluripotent cells using said component, and medium comprising said component |
abstract |
The purpose of the present invention is to provide a pluripotent cell that is very safe in regenerative medical treatment applications, and a manufacturing method therefor. The purpose of the present invention is also to provide a pluripotent cell with fewer safety concerns, particularly problems such as the malignant transformation of the cells or the presence of microbes in the cells, and a manufacturing method therefor. The present invention provides a method for manufacturing pluripotent cells from somatic cells. Said method comprises a process for bringing somatic cells into contact with a glycoprotein-containing component that can be obtained from fermentative microbes and is capable of inducing cell re-programming. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702636-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729723-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015174364-A1 |
priorityDate |
2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |